| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
This report analyzes the prevalent stem cell technologies and the therapeutic
areas in which stem cells find their applications. The study provides a market
insight into the ever progressing and debatable market of Stem Cell Research
segmented by type, technology and therapeutic area. Stem Cells by Type are
further classified into Adult Stem Cells, Embryonic Stem Cells, and Cord Blood
Stem Cells. Stem Cell Research by Technology is segmented into Stem Cell
Transplantation, Cell Based Genomics, Xenotransplantation, Cord Blood Banking,
and Other. The Therapeutic applications of Stem Cell Research are analyzed by
area into Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology,
Diabetes, Dermatology and Other. Projections and estimates are graphically
illustrated by geographic regions encompassing North America, Europe,
Asia-Pacific, and Rest of World. Business profiles of 61 major companies are
discussed in the report. The report serves as a guide to global Stem Cell
industry covering 744 companies that are engaged in stem cell R&D, storage,
banking, discovery, testing and supply of products and services. Major
Contract Research Organizations and Universities serving the industry are also
covered in the Corporate Directory section of this report. Information related
to recent product releases, product developments, partnerships,
collaborations, mergers and acquisitions, ethical issues, regulatory affairs,
and other areas of concern is also covered in the report. Exclusive graphical
representations are provided for 170 exhibits.
TABLE OF CONTENTS
I. SCOPE AND METHODOLOGY
II. REPORT SYNOPSIS
- 1. Foreword
- Stem Cells
- Segmentation of Stem Cells
- Exhibit 1: Segmentation of Global Stem Cells Market by Stem Cell Type
(Adult Stem Cells, Embryonic Stem Cells and Cord Blood Stem Cells),
Technology (SC Transplantation, Cell Based Genomics, Xenotransplantation,
Cord Blood Banking and Other) and Therapeutic Area (Neurology, Bone and
Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other)
- 2. Global Market Analysis
- Exhibit 2: Stem Cells (2005-2012) - Global Market Analysis (Current &
Future) in US$ Million (Graphical Representation included)
- Analysis by Stem Cell Type
- Adult Stem Cells
- Market Overview
- Exhibit 3: Adult Stem Cells (2005-2012) - Global Market Analysis
(Current & Future) by Geographic Region for North America, Europe,
Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 4: Adult Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Global Market Value by Geographic Region for North
America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Cord Blood Stem Cells
- Market Overview
- Exhibit 5: Cord Blood Stem Cells (2005-2012) - Global Market
Analysis (Current & Future) by Geographic Region for North America,
Europe, Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 6: Cord Blood Stem Cells (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Embryonic Stem Cells
- Market Overview
- Exhibit 7: Embryonic Stem Cells (2005-2012) - Global Market
Analysis (Current & Future) by Geographic Region for North America,
Europe, Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 8: Embryonic Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Global Market Value by Geographic Region for North
America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Analysis by Technology
- Stem Cell Transplantation
- Market Overview
- Exhibit 9: Stem Cell Transplantation (2005-2012) - Global Market
Analysis (Current & Future) by Geographic Region for North America,
Europe, Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 10: Stem Cell Transplantation (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Cell Based Genomics
- Market Overview
- Exhibit 11: Cell Based (CB) Genomics (2005-2012) - Global Market
Analysis (Current & Future) by Geographic Region for North America,
Europe, Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 12: Cell Based (CB) Genomics (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Xenotransplantation
- Market Overview
- Exhibit 13: Xenotransplantation (2005-2012) - Global Market
Analysis (Current & Future) by Geographic Region for North America,
Europe, Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 14: Xenotransplantation (2006, 2009 and 2012) - Percentage
Breakdown of Global Market Value by Geographic Region for North
America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Cord Blood Banking
- Market Overview
- Exhibit 15: Cord Blood Banking (2005-2012) - Global Market
Analysis (Current & Future) by Geographic Region for North America,
Europe, Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 16: Cord Blood Banking (2006, 2009 and 2012) - Percentage
Breakdown of Global Market Value by Geographic Region for North
America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Other
- Exhibit 17: Other Stem Cell Technologies (2005-2012) - Global Market
Analysis (Current & Future) by Geographic Region for North America,
Europe, Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 18: Other Stem Cell Technologies (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Analysis by Therapeutic Area
- Neurology
- Market Overview
- Exhibit 19: Stem Cells in Neurology (2005-2012) - Global Market
Analysis (Current & Future) by Geographic Region for North America,
Europe, Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 20: Stem Cells in Neurology (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Bone and Cartilage
- Market Overview
- Exhibit 21: Stem Cells in Bone and Cartilage Therapy (2005-2012) -
Global Market Analysis (Current & Future) by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World in US$ Million
(Graphical Representation included)
- Exhibit 22: Stem Cells in Bone and Cartilage Therapy (2006, 2009
and 2012) - Percentage Breakdown of Global Market Value by Geographic
Region for North America, Europe, Asia-Pacific and Rest of World
(Graphical Representation included)
- Cancer
- Market Overview
- Exhibit 23: Stem Cells in Cancer Therapy (2005-2012) - Global
Market Analysis (Current & Future) by Geographic Region for North
America, Europe, Asia-Pacific and Rest of World in US$ Million
(Graphical Representation included)
- Exhibit 24: Stem Cells in Cancer Therapy (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Hematology
- Market Overview
- Exhibit 25: Stem Cells in Hematology (2005-2012) - Global Market
Analysis (Current & Future) by Geographic Region for North America,
Europe, Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 26: Stem Cells in Hematology (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Cardiology
- Market Overview
- Exhibit 27: Stem Cells in Cardiology (2005-2012) - Global Market
Analysis (Current & Future) by Geographic Region for North America,
Europe, Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 28: Stem Cells in Cardiology (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Dermatology
- Market Overview
- Exhibit 29: Stem Cells in Dermatology (2005-2012) - Global Market
Analysis (Current & Future) by Geographic Region for North America,
Europe, Asia-Pacific and Rest of World in US$ Million (Graphical
Representation included)
- Exhibit 30: Stem Cells in Dermatology (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Diabetes
- Market Overview
- Exhibit 31: Stem Cells in Diabetes Treatment (2005-2012) - Global
Market Analysis (Current & Future) by Geographic Region for North
America, Europe, Asia-Pacific and Rest of World in US$ Million
(Graphical Representation included)
- Exhibit 32: Stem Cells in Diabetes Treatment (2006, 2009 and 2012)
- Percentage Breakdown of Global Market Value by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Other
- Exhibit 33: Stem Cells in Other Therapeutics (2005-2012) - Global
Market Analysis (Current & Future) by Geographic Region for North
America, Europe, Asia-Pacific and Rest of World in US$ Million
(Graphical Representation included)
- Exhibit 34: Stem Cells in Other Therapeutics (2006, 2009 and 2012) -
Percentage Breakdown of Global Market Value by Geographic Region for
North America, Europe, Asia-Pacific and Rest of World (Graphical
Representation included)
- Exhibit 35: List of Major Global Companies
- 3. Regional Market Analysis
- North America
- Exhibit 36: Stem Cells (2005-2012) - North American Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Europe
- Exhibit 37: Stem Cells (2005-2012) - European Market Analysis (Current
& Future) in US$ Million (Graphical Representation included)
- Asia-Pacific
- Exhibit 38: Stem Cells (2005-2012) - Asia-Pacific Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Rest of World
- Exhibit 39: Stem Cells (2005-2012) - Rest of World Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
III. PRODUCT/TECHNOLOGY RESEARCH
- 1. Introduction
- Stem Cells
- Stem Cells Growth Trends - Global Markets
- Exhibit 40: Global Market for Stem Cells: Geographic Regions
(Asia-Pacific, Europe, North America and Rest of World) Ranked by
Projected CAGR for 2005 through 2012 (Graphical Representation included)
- Cell Differentiation
- Totipotent Stem Cells
- Pluripotent Stem Cells
- Multipotent Stem Cells
- Unipotent Stem Cells
- Importance of Stem Cells
- Stem Cell Research
- Backdrop
- Major Milestones in Stem Cell Research
- Exhibit 41: The Evolution of Stem Cell Research
- Categorization of Stem Cells
- Global Market Growth Trends - Stem Cell Categories
- Exhibit 42: Global Market for Stem Cells: Major Stem Cell
Categories (CB Stem Cell, Embryonic Stem Cell and Adult Stem Cell)
Ranked by Projected CAGR for 2005 through 2012 (Graphical
Representation included)
- Embryonic Stem Cells
- Derivation of Embryonic Stem Cells
- Differentiation of hESCs
- Directed Differentiation
- Directed Differentiation of hESCs in Chemically Defined Medium
Conditions
- Adult Stem Cells
- Various Tests for Detection of Adult Stem Cells
- Differentiation of Adult Stem Cells
- Adult Stem Cell Plasticity and Transdifferntiation
- Applications of Adult Stem Cells
- Major Disease Areas of Adult Stem Cells
- Cord Blood Stem Cells
- Derivation of Stem Cells: Cord Blood Vs Bone Marrow
- Stem Cells and Technologies
- Growth Trends - Global Stem Cell Technologies
- Exhibit 43: Global Market for Stem Cells: Major Stem Cell
Technologies (Cord Blood Banking, Xenotransplantation, SC
Transplantation, Cell Based Genomics and Other) Ranked by Projected CAGR
for 2005 through 2012 (Graphical Representation included)
- Stem Cell Transplantation
- Need for Stem Cell Transplantation
- The Process of Stem Cell Transplantation
- Growth Trends - Global Market for Stem Cell Transplantation
- Exhibit 44: Global Market for Stem Cell Transplantation:
Geographic Regions (Asia-Pacific, North America, Europe and Rest of
World) Ranked by Projected CAGR for 2005 through 2012 (Graphical
Representation included)
- Cell Based Genomics
- Growth Trends - Global Market for Cell Based Genomics
- Exhibit 45: Global Market for Cell Based Genomics: Geographic
Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked
by Projected CAGR for 2005 through 2012 (Graphical Representation
included)
- Xenotransplantation
- Malfunctioning of Stem Cells Used for Xenotransplantation
- Growth Trends - Global Market for Xenotransplantation
- Exhibit 46: Global Market for Xenotransplantation: Geographic
Regions (Asia-Pacific, North America, Europe and Rest of World) Ranked
by Projected CAGR for 2005 through 2012 (Graphical Representation
included)
- Cord Blood Banking
- Exhibit 47: Global Private Cord Blood Banks by Geographic Region
(2006) (Graphical Representation included)
- Applications of Cord Blood
- Growth Trends - Global Market for Cord Blood Banking
- Exhibit 48: Global Market for Cord Blood Banking: Geographic
Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked
by Projected CAGR for 2005 through 2012 (Graphical Representation
included)
- Other Technologies Related to Stem Cells
- Stem Cell Research and Cloning
- The Process of Cloning
- Stem cell cultivation
- How Stem Cell Research Differs from Cloning?
- Stem Cell Therapy and Mammalian Cloning
- Cloning Technologies
- Therapeutic Cloning
- Reproductive Cloning
- Somatic Cell Nuclear Transfer
- Concerns with Stem Cell Research
- Ethical Issues in Stem Cell Research
- 2. Embryonic Stem Cell Research
- Growth Trends - Global Market for Embryonic Stem Cells
- Exhibit 49: Global Market for Embryonic Stem Cells: Geographic Regions
(Asia-Pacific, North America, Europe and Rest of World) Ranked by
Projected CAGR for 2005 through 2012 (Graphical Representation included)
- Therapeutic Applications and Research Prospects
- Multipotent Adult Progenitor Cells
- Therapeutic Applications - The ESC Approach
- Human ESCs Replication for Tissue Repair and Transplantation
- Embryonic Stem Cells Application for Heart Disease
- Human and Mouse Embryonic Stem Cell - The Proteomic Approach
- Undifferentiated Human Embryonic Stem Cells for Formation of Blood
Cells
- Human Embryonic Stem Cell (hESC) Lines
- Embryo Selection
- The Process of hESCs Derivation
- Blastocyst Embryo Transfer
- Genetic Handling of hESCs
- hESC Markers
- Single-Cell Embryo Biopsy
- Stem Cell Derivation through Embryo Biopsy
- 3. Adult Stem Cell Research
- Growth Trends - Global Market for Adult Stem Cells
- Exhibit 50: Global Market for Adult Stem Cells: Geographic Regions
(Asia-Pacific, Europe, North America and Rest of World) Ranked by
Projected CAGR for 2005 through 2012 (Graphical Representation included)
- Types of HSCs
- The Short-Term Precursor or Progenitor Cells
- The Long-Term HSCs
- Characteristics of HSCs
- Sources of Hematopoietic Stem Cells
- Bone Marrow
- Peripheral Circulating Blood
- Advantages of HSCs
- Challenges in the Research of HSCs
- Clinical Application of Hematopoietic Stem Cells
- Leukemia and Lymphoma
- Hereditary Blood Disorders
- Hematopoietic Stem Cell Rescue in Treatment of Cancer
- Treatment of Cancerous Tumors
- Other Applications of HSCs
- Plasticity of Hematopoietic Stem Cells
- Challenges in Developing HSC Treatments
- 4. Cord Blood Stem Cells
- Growth Trends - Global Market for Cord Blood Stem Cells
- Exhibit 51: Global Market for Cord Blood Stem Cells: Geographic
Regions (Asia-Pacific, North America, Europe and Rest of World) Ranked by
Projected CAGR for 2005 through 2012 (Graphical Representation included)
- Collection Process of Cord Blood
- Cryo-Preservation of Cord Blood Stem Cells
- Artificial Cryo-Preservation
- Advantages of Cord Blood
- 5. Stem Cells in Therapeutics
- Growth Trends - Global Stem Cell Therapeutic Areas
- Exhibit 52: Global Market for Stem Cells: Major Therapeutic Areas
(Neurology, Bone and Cartilage, Dermatology, Diabetes, Hematology,
Cardiology, Cancer and Other) Ranked by Projected CAGR for 2005 through
2012 (Graphical Representation included)
- Cancer
- BMT and PBSCT: Cancer Treatment
- BMT and PBSCT - Cancer Types
- Extraction of Stem Cells
- Extraction from Bone Marrow
- Risk Factors for the Donor
- Extraction from Peripheral Blood
- Risk Factors for the Donor
- Extraction from Umbilical Cord
- Cancer Stem Cell Transplant Process
- Mini-Transplant
- Tandem Transplant
- Post Transplant Functioning of Stem Cells
- Expenses for BMT or PBSCT
- Cancer Immunotherapy
- Scientific Resources of Cancer Immunotherapy
- NK-92 Cell Based Cancer Therapy
- Genetically Modified NK-92 Cells for Cancer Therapy
- Stem Cell Vaccines for Cancer Therapy - Developed by Gene Modification
- Dendritic Cell Vaccines
- Fundamentals of Dendritic Cell Vaccines
- The B-Cell Vaccine variety
- Hybrid Cell vaccination
- General Side Effects with Stem Cell Transplantation
- Consequences and Medication
- Complications with PBSCT in Breast Cancer Patients
- Growth Trends - Global Market for Stem Cells in Cancer Treatment
- Exhibit 53: Global Market for Stem Cells in Cancer Treatment:
Geographic Regions (Asia-Pacific, North America, Europe and Rest of
World) Ranked by Projected CAGR for 2005 through 2012 (Graphical
Representation included)
- Cardiovascular Disorders
- Cardiac Stem Cells
- Myocyte Formation from Cardiac Stem Cells
- Stem Cell Transplants for Congestive Heart Failure
- Autologous Adult Stem Cell Transplantation
- Myocardial Regeneration
- Treatment for Ischemic Heart Failure with Cellular Cardiomyoplasty
- The Relation between Left Ventricular Function and Release of
Cardioactive Cytokines
- Cell-Based Myocardial Repair
- Autologous Skeletal Myoblasts
- Cardiocytes and Stem Cells
- Stem Cells Therapeutic Application for Cardiovascular Syndrome
- Severe Coronary Artery Disease - Stem Cell Approach
- Stem Cells Therapy for Hepatic Disorders
- Growth Trends - Global Market for Stem Cells in Cardiovascular
Disorders Treatment
- Exhibit 54: Global Market for Stem Cells in Cardiovascular Disorders
Treatment: Geographic Regions (Asia-Pacific, Europe, North America and
Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical
Representation included)
- Neurological Disorders - Stem Cell Therapy
- Properties of Neural Stem Cells
- Transformation of Neural Stem Cells into Other Cell Types
- The Process of Transformation
- Molecular Mechanisms
- Stem Cells in Other Neoplasms
- Cell Therapy for Neurodegenerative Disorders
- Can Alzheimer's be cured with Stem Cells?
- Alternative Methods for Alzheimer's Treatment
- Stem Cell Therapy for Amyotrophic Lateral Sclerosis
- Stroke Therapy using Human Adult Neural Stem Cells
- Cerebral Palsy Treatment - The Stem Cell Approach
- Role of Chemokines
- Techniques and Risks for Stem Cell Therapy
- Stem Cell Therapy for Traumatic Brain Injury
- Stem Cell Transplantation - A Novel Approach to Epilepsy Treatment
- Growth Trends - Global Market for Stem Cells in Neurological Disorders
Treatment
- Exhibit 55: Global Market for Stem Cells in Neurological Disorders
Treatment: Geographic Regions (Asia-Pacific, Europe, North America and
Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical
Representation included)
- Bone and Cartilage Regeneration
- Application of Mesenchymal Stem Cells in Regeneration of Bone
- Molecular and Tissue Engineering Strategies for the Use of Mesenchymal
Stem Cells in Bone Regeneration
- Application of Adult Stem Cells in Cartilage Regeneration and Tissue
Engineering
- About Mesenchymal Stem Cells
- Clinical Applications and Future of Cell Therapy
- Growth Trends - Global Market for Stem Cells in Bone and Cartilage
Disorders Treatment
- Exhibit 56: Global Market for Stem Cells in Bone and Cartilage
Disorders Treatment: Geographic Regions (Asia-Pacific, Europe, North
America and Rest of World) Ranked by Projected CAGR for 2005 through
2012 (Graphical Representation included)
- Hematological Disorders
- Treatment for Blood Disorders
- Stem Cell Treatment for Blood Disorder
- Sickle Cell Anemia
- Gene Therapy
- Stem Cell Transplantation
- Cord Blood Transplantation
- Growth Trends - Global Market for Stem Cells in Hematology
- Exhibit 57: Global Market for Stem Cells in Hematology: Geographic
Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked
by Projected CAGR for 2005 through 2012 (Graphical Representation
included)
- Stem Cell Therapy for Diabetes Mellitus
- Type 1 Diabetes in Children
- Cord Blood Stem Cells for Treatment of Type 1 Diabetes
- Growth Trends - Global Market for Stem Cells in Diabetes Treatment
- Exhibit 58: Global Market for Stem Cells in Diabetes Treatment:
Geographic Regions (Asia-Pacific, Europe, North America and Rest of
World) Ranked by Projected CAGR for 2005 through 2012 (Graphical
Representation included)
- Stem Cell Therapy in Dermatology
- Cosmetic Applications
- Intended Accomplishment by Stem Cells in Cosmetology
- Growth Trends - Global Market for Stem Cells in Dermatology
- Exhibit 59: Global Market for Stem Cells in Dermatology: Geographic
Regions (Asia-Pacific, North America, Europe and Rest of World) Ranked
by Projected CAGR for 2005 through 2012 (Graphical Representation
included)
- Stem Cells Research - A New Hope in Cosmetology
- Breast Enhancement Treatment using Stem Cells
- Effectiveness of Stem Cells in Rejuvenating Skin
- Medicinal and Cosmetic Applications of Fat Derived Stem Cells
- Bone and Muscles from Skin Stem Cells
- Genetic Cosmetics - A Solution for Aging skin
- Stem Cell Based Therapeutic Application for Treatment of Eyes and an
Unusual Skin Disorder
- Stem Cell Aging Control by Extrinsic and Intrinsic Process
- Adult Stem Cells - Creation of Soft Tissue
- Other Major Therapeutic Areas of Stem Cells
- Renal Applications
- The Renal Papilla is Niche for Adult Kidney Cells
- Stem Cell Applications in Transplantable Organs
- Orthopedic Applications
- Spinal Cord Regeneration
- Review of Various Cell Therapies Used In the Field Of Orthopedics
- Endocrine Applications of Stem Cells
- Ophthalmic Applications of Stem cells
- Prospects of Stem-Cell Based Treatment for Eye Disorders
- Stem Cells Research in Neurology
- Stem Cells Research in Dentistry
- 6. Technological Advances
- Identification of a Versatile Stem Cell in the Amniotic Fluid
- Why Caucasians are more in Number among Stem Cell Transplant Recipients?
- The Creation of Tissue-Matched Stem Cells in Mice without the Cloning
Process
- Stem Cell Transplants -- Increased Risk for Diabetes and Hypertension
- The Generation of Human Embryonic Stem Cell Lines from Dead Embryos
- Self-Renewal of Embryonic Stem Cells Dependent upon the Small Molecule
- 7. Prospective Applications
IV. MARKET DYNAMICS
- 1. Market Overview
- Global Market Analysis
- Exhibit 60: Stem Cells (2005-2012) - Global Market Analysis (Current &
Future) by Geographic Region for North America, Europe, Asia-Pacific and
Rest of World in US$ Million (Graphical Representation included)
- Exhibit 61: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of
Global Market Value by Geographic Region for North America, Europe,
Asia-Pacific and Rest of World (Graphical Representation included)
- 2. Stem Cell Trends
- The Future of Cloned Food
- Adult Stem Cells to Play Key Role in Heart Diseases
- Use of Robotics in Stem Cell Research Automation
- Identification of New Stem Cell with Dual Characteristics
- Stem Cell Derivation from a Single Cell Extracted from Early Human
Embryos
- Reprogramming of Adult Stem Cells
- Adult Stem Cells - Free of Controversy and Yield Better Results
- Stem Cell Research Prospects in China
- 3. Major Companies in Stem Cell Market
- Aastrom Biosciences, Inc. (USA)
- Advanced Cell Technology, Inc. (USA)
- Aldagen, Inc. (USA)
- Angel BioTechnology Holdings PLC (UK)
- Axordia Ltd. (UK)
- BioE Corporation (USA)
- BrainStorm Cell Therapeutics, Inc. (USA)
- Cellartis AB (Sweden)
- Cellerant Therapeutics, Inc. (USA)
- Cellerix SA (Spain)
- Cells4Life Ltd. (UK)
- Cellular Dynamics International (USA)
- CordLife Ltd. (Australia)
- Cryo-Cell International, Inc. (USA)
- CryoGENESIS International Ltd (UK)
- Cryo-Save AG (The Netherlands)
- Cytori Therapeutics, Inc. (USA)
- Epistem PLC (UK)
- ES Cell International Pte Ltd. (Singapore)
- Gamida Cell Ltd. (Israel)
- GE Healthcare (UK)
- Geron Corporation (USA)
- Invitrogen Corp. (USA)
- Lazaron Biotechnologies (SA) Ltd. (South Africa)
- LifebankUSA (USA)
- LifeCell Corporation (USA)
- MaxCyte, Inc. (USA)
- Mesoblast Ltd. (Australia)
- Millipore Corporation (USA)
- NeuroGeneration, Inc. (USA)
- Novartis AG (Switzerland)
- NovaThera Ltd (UK)
- Novo Nordisk A/B (Denmark)
- Novocell, Inc. (USA)
- Osiris Therapeutics, Inc. (USA)
- RegenTec Ltd. (UK)
- ReInnervate Ltd. (UK)
- Reliance Life Sciences (India)
- ReNeuron Group PLC (UK)
- RhinoCyte, Inc. (USA)
- Stem Cell Innovation, Inc. (USA)
- Stem Cell Sciences KK (Japan)
- Stem Cell Sciences PLC (UK)
- Stem Cell Technology Company (Iran)
- Stem Cell Therapeutics Corporation (Canada)
- StemCell Technologies, Inc. (USA)
- StemCells Inc. (USA)
- Takara Bio, Inc. (Japan)
- Vesta Therapeutics Inc. (USA)
- Viacord (USA)
- VistaGen Therapeutics, Inc. (USA)
- Zellwerk GmbH (Germany)
- 4. Major Activities in Stem Cell Market
- FDA Postpones Geron Corp's Embryonic Stem Cells Clinical Trials
- WARF Grants License to Invitrogen for Research with Karyotypically
Normal Human Embryonic Stem Cell
- University of Edinburgh Receives Two Grants from UK Stem Cell Foundation
for Collaborative Research with Geron Corp.
- New Business Enterprise Formed to Develop Treatment with Adult and Cord
Blood Stem Cells
- Celgene Cellular Therapeutics succeeds in Transplanting Stem Cells
obtained from Human Placenta for correcting Hematopoietic Disturbances
- KCI Acquires LifeCell for $1 Billion in Cash
- Osiris in Sale Agreement with NuVasive for Osteocel®
- Stem Cell Sciences Awarded US Patent for Stem Cell Media
- International Stem Cell Corporation Receives Exclusive Rights for
Supplying Artificially Developed Human Skin Models
- Neuralstem Receives European Patent for Crucial Stem Cells related
Technology
- UCSD Joins consortium of Institutions for Research on Regenerative
Technologies
- MicroIslet Receives Grant from National Institute of Health
- Queensland gets a New Stem Cell Research Facility
- Cordlife Ltd. Granted License to Establish New Cord Blood Stem Cells
Bank in India
- StemCells Receives Crucial US Patent related to Human Neural Stem Cells
- Asia-Cryo Cell Renamed as LifeCell International
- Pentagon to Partially Finance a New Research on Regeneration of Limbs
- CordLife Launches Largest Southeast Asian Cord Blood Bank in Singapore
- MediHealth and NovaThera in Manufacturing and Marketing Agreement for
NovaPod™
- VistaGen Therapeutics in Stem Cell R&D Alliance with University Health
Network of Toronto and the McEwen Centre for Regenerative Medicine
- Stem Cell Therapy International Plans Merger with Histostem
- Cellartis and Pfizer in Research Collaboration for Development of
Screening System to Detect Human Toxicity
- US Patent to Geron for Production of Pancreatic Islets from Human
Embryonic Stem Cells
- Angioblast and Abbott in Heart Therapy Collaboration
- Angel Biotechnology Enters into New GMP Manufacturing Contract
- BrainStorm and Rutgers University to Develop Spinal Cord Injury Therapy
in Collaboration
- StemCells, Inc. and Casey Eye Institute in Research Collaboration
- Osiris Obtains $224 Million Department of Defense Contract for
Prochymal™
- Stem Cell Sciences in Diabetes R&D Agreement with a Major Pharmaceutical
Company
- StemCell Technologies, Inc., is now a Subsidiary of NeoStem, Inc
- Millipore Enters into Partnership Agreement with Abeome for Supplying
Monoclonal Antibodies for Application in Stem Cell Research
- PerkinElmer, Inc. Acquires ViaCell, Inc
- ECI starts Production of Clinical-Grade Stem Cell Lines
- Stem Cell Sciences, Plc Regains Global Rights to Neural Stem Cell
Technology
- Innovative Muscle Stem Cells Discovery Acquired by Stem Cell Sciences
- Celera Completes Acquisition of Atria Genetics, Inc.
- Artificial Life Enters into Collaboration with BeFutur Biotechnologies
- Cytori Receives Approval for Celution™ System in Japan
- Advanced Cell Technology Acquires Complete Stake in Mytogen
- Thermo Fisher Scientific and Cellular Engineering Technologies form
Partnership Alliance
- Osiris Associates with Genzyme for Developing Medical Countermeasures
for Nuclear and Radiological Intimidation
- ReNeuron Acquires Business Assets of AmCyte Inc,.
- Summit is the New Name for Vastox
- ReproCELL Enters into Collaboration Agreement with ReproCELL for
Enhancing the Studies Based on Stem Cell
- Stemcell Pharma Merges with Zandcell
- Pioneer Surgical Technology Enters the Orthobiologics Market with its
Acquisition of Encelle, Inc.
- Wisconsin Alumni Research Foundation Grants Worldwide Licenses to Stem
Cell Technologies and BD Biosciences
- Cytori Sells HYDROSORB™ Surgical Implant Product Line to Kensey
Nash
- Stanford Researchers Announce New Discovery in the Field of Human Stem
Cells Transplantation
- BioEden Expands Operations into Europe
- Vitrolife Enters into Collaboration with Cellartis
- Stem Cell Sciences Acquires Rights to Novel Discovery Technology for the
Production of Human Stem Cells
- Geron Acquires Additional Stake in TA Therapeutics Joint Venture
- Roslin Researchers Derive Stem Cells from New Source
- ReNeuron Scientists Announce Generation of Pancreatic Cell Lines
- Discovery in ZebraFish may aid Human Blood Cell Transplants
- Stem Cell Innovations Enters into Collaboration with High Q Foundation
- Stem Cells to Replace Damaged Heart Muscle
- Advanced Cell Technology Announces the Development of hESC Line without
Damaging an Embryo
- Canadian Researchers Redefine Stem Cells
- ThermoGenesis Enters into Agreement with University of California (UC)
Stem Cell Program (SCP)
- Stem Cell Innovations and TNO Enter into Collaboration
- Pluristem Purchases Patents for the 3-D Expansion of Human Cells
- Epistem and AstraZeneca Undertake Joint Studies on the Development of
Novel Cancer Drugs Employing the Biomarker Technology
- BioE Enters into Collaboration with Phillips Plastics for Developing and
Marketing Stem Cell Therapeutics
- NovaThera Enters into Alliance with Gamida Cell Developing Cell-based
Therapeutics
- Invitrogen Joins Hands with Cytori for Providing Research Products Based
on Adipose Stem Cell
- ReNeuron Group goes for Alliance to Upgrade its Stem Cell Expansion
Technology
- H. Lundbeck Enters into Agreement with Stem Cell Innovations, Inc
- Consensus Business Group Acquires Stake in Hadasit Bio-Holdings
- StemLifeLine Introduces Premier Service for the Development of Personal
Stem Cell Lines
- Israeli Government Grants US$ 830,000 to Pluristem
- Lexicon Genetics now Called Lexicon Pharmaceuticals Continues with its
Drug Development Pipeline
- ThromboGenics Enters into License Agreement with Millipore
- Amatokin launched in the US
- Calbatech Establishes a Subsidiary Company for Offering Stem Cell
Service in the UK
- Stemcell Signs Agreement with Aldagen for Supplying Aldecount
- Pluristem Enters into a Licensing Agreement with Stem Cell
- Celogos Grants License for its Autogenous Myoblast Transplantation for
Urinary Incontinence Therapy to Stem Cell Sciences KK
- Merck & Co obtains Neural Stem Cells and Technology for Research
- DSM Extends Partnership Agreement with Crucell
- Merck Receives Licenses of Neural Stem Cell Technology from SCS
- SCS Enters into MTA Pact with Henderson
- Angel Biotechnology Enters into Alliance with CellGenea
- MC Employs HEScGRO™ Medium Human Embryonic Stem Cell Study
- Chromos Signs Contract with Genitope
- ACT Acquires Technology Assets of Infigen
- BCT Undertakes Research on Stem Cell Safety in Primates for Curing
Parkinson's
- TIGENIX Joins Hands with FIDIA for Developing New Biological Implants
- ES Cell Signs License Agreement with ITI
- Stem Cell Innovations Signs Collaboration Agreement with ALSA
- CyGenics Signs Partnership Agreement with ZBC
- Mediatech Enters into Alliance with GlobalStem
- Gamida Cell Enters into SPA Agreement with FDA
- Vistagen Reinforces its Partnership with Sanwa
- StemCells Carries out Phase I Studies of HuCNS-SC™
- Aldagen Joins Hands with IMT
- Chromos Signs Contract with Y's Therapeutics for Developing Cell Line
- Geron Signs Collaboration Agreement with The University of Edinburgh
- ACT Develops New Technology for hES Cells Culture
- Stem Cell Sciences Partners with Neurosolutions
- Cambrex Joins Hands with Cytori to Market Stem Cell Products
- ViaCell Enters into Alliance with Centocor
- Pierre Fabre Employs SURE Technology for Developing Mammalian Cell Lines
- PrimeGen Emphasizes on PrimeCell™ Development
- CellResearch Develops New Range of Cord Lining Stem Cells
- Geron Joins Hands with University of Oxford
- Cryo-Cell Commences Web-Interface for Placental Stem cells
- Aldagen Receives US Patent Rights for Key Stem Cell
- Geron Signs Pact with MaxCyte
- Vitro Joins Hands with PhosphoSolutions for Stem Cell Proteomics Study
- Xcyte Merges with Cyclacel to Form Biopharmaceutical MNC
- StemCo Adopts New Corporate Identity (Aldagen)
- Cytori Therapeutics Signs Collaboration Agreement with Olympus
- Cryo-Cell Signs Global Marketing Agreement with Plureon
- Artificial Life Associates with BeFutur
- LCT Enters into Joint Venture Agreement with MultiCell
- SAFC Biosciences Signs Partnership Agreement with Chromos
- Axordia Enters into Collaboration with Chemicon for Developing Human
Embryonic Stem Cell Antibody Markers
- A.C.T. Renames as Advanced Cell Technology
- U.S. BioDefense Enteres into Collaboration with University of Texas
- ViaCell Enters into Alliance with Genzyme on Diabetes Program
- Geron Enters into Alliance with Cambrex to Develop and Market Human Cell
Lines
- 5. Major Product Innovations / Launches
- StemCor Systems to Receive NIH SBIR Grant for Bone Marrow Harvesting
Product231
- Human Parthenogenetic Stem Cells Developed by International Stem Cell
Corporation being Examined for Potential in Treating Liver Diseases
- Invitrogen Introduces Animal Origin Free Substrate for Stem Cells
- FDA allows Osiris Therapeutics to Initiate Expanded Access Program with
Prochymal
- Stemcell Acquires Geron Intellectual Property to Develop Media and
Matrices for Stem Cell Growth
- FDA Allows University of Miami and BioCardia for Testing of Two Adult
Stem Cell based Products
- Researchers at Standford Succeed in Creating Cancer Stem Cells from
Normal Skin Cells
- ImmuneRegen® Joins with BioCure for Developing New Wound-Healing
Therapy
- Lifebank Corp., Introduces Sterile Field Cord Blood Collection unit in
the Country
- TaiGen Initiates US FDA Phase I trials of TG-0054, a Stem Cell Mobilizer
- Aldagen Announces First Patient Treated
- Enrollment Completed for Investigator-Initiated Stem & Regenerative Cell
Breast Augmentation Study in Japan
- Allogeneic Cells of Mesoblast Provide Sustained effect in Knee
Osteoarthritis Preclinical Trials
- VistaGen to Isolate Earliest Embryonic Stem Cell-Derived Human Cardiac
Cell
- StemCell Technologies Launches New Procedure to Identify and Quantify
Neural Stem and Progenitor Cells in Vitro
- Efficient Generation of Functional Hepatocytes (Liver cells) from Human
Embryonic Stem Cells by Advanced Cell Technology
- Stem Cells of Mesoblast Provide Rapid Fracture Healing in Clinical Trials
- Stem Cell Tested Initiative Millicell® 1 m Plates Second Qualified
Product of Millipore
- Novocell Successfully Utilizes Stem Cells for Insulin Generation in Mice
- Autologous Stem Cell Therapy to First Patient by Aastrom
- Cytori Treats First Patients in its Stem & Regenerative Cell Heart
Attack Study
- Osiris Therapeutics Reclaim Worldwide Rights to Prochymal
- Millipore to Offer Stem Cell Tested Products
- MediHealth and NovaThera Develop the Innovative NovaPod™ Designed
for Stem Cell Based Applications
- Invitrogen Launches STEMPRO(R) EZChek(TM) Multiplex PCR Kit
- Invitrogen Launches Innovative Media Designed for hESCs
- BD Biosciences Associates with Stemcell Technologies to Introduce
Advanced Culture Environment for Application in hESC Research
- Invitrogen Introduces New Engineered Stem Cell Line
- Millipore Launches MEL Cell Lines
- Cells4Life Launches Guava PCA System
- MIT Announces Release of Firefly 3000 Protein Assay Platform
- GE Healthcare Releases AXP AutoXpress Platform
- ReNeuron and Millipore Introduce ReNcellTM Neural Stem Cell Lines
- 6. Regional Market Analysis
- A. North America
- Market Analysis
- Exhibit 62: Stem Cells (2005-2012) - North American Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 63: List of Major Companies in North America
- Analysis by Geographic Region
- Exhibit 64: Stem Cells (2005-2012) - North American Market
Analysis (Current & Future) by Geographic Region for United States,
Canada and Mexico in US$ Million (Graphical Representation included)
- Exhibit 65: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of North American Market Value by Geographic Region for
United States, Canada and Mexico
- Analysis by Stem Cell Type
- Exhibit 66: Stem Cells (2005-2012) - North American Market
Analysis (Current & Future) by Category for Adult Stem Cells, Cord
Blood Stem Cells and Embryonic Stem Cells in US$ Million (Graphical
Representation included)
- Exhibit 67: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown ofNorth American Market Value by Category for Adult Stem
Cells, Cord Blood Stem Cells and Embryonic Stem Cells
- Analysis by Technology
- Exhibit 68: Stem Cells (2005-2012) - North American Market
Analysis (Current & Future) by Stem Cell Technology for Stem Cell (SC)
Transplantation, Cell Based (CB) Genomics, Xenotransplantation, Cord
Blood Banking and Other in US$ Million (Graphical Representation
included)
- Exhibit 69: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of North American Market Value by Stem Cell Technology for
Stem Cell (SC) Transplantation, Cell Based (CB) Genomics,
Xenotransplantation, Cord Blood Banking and Other
- Analysis by Therapeutic Area
- Exhibit 70: Stem Cells (2005-2012) - North American Market
Analysis (Current & Future) by Therapeutic Area for Neurology, Bone
and Cartilage, Cancer, Hematology, Cardiology, Dermatology, Diabetes
and *Other in US$ Million (Graphical Representation included)
- Exhibit 71: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of North American Market Value by Therapeutic Area for
Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology,
Dermatology, Diabetes and Other
- North American Stem Cell Market By Country
- A1. United States
- The US Market Scenario
- The President's Criteria
- The Role of the NIH
- The US Backs Stem Cell Research
- The US Market Analysis
- Exhibit 72: Stem Cells (2005-2012) - United States Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 73: List of Cord Blood/Stem Cell Banks in the United States
- A2. Canada
- Canadian Market Scenario
- Guidelines for Stem Cell Research
- Canadian Cord Blood Banking Sector
- Canadian Market Analysis
- Exhibit 74: Stem Cells (2005-2012) - Canadian Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 75: List of Cord Blood/Stem Cell Banks in Canada
- A3. Mexico
- Mexican Market Scenario
- Mexican Market Analysis
- Exhibit 76: Stem Cells (2005-2012) - Mexican Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 77: List of Cord Blood/Stem Cell Banks in Mexico
- B. Europe
- Funding for Stem Cell Research in Europe
- Cord Blood Banking in Europe
- Market Analysis
- Exhibit 78: Stem Cells (2005-2012) - European Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 79: List of Major Companies in Europe
- Analysis by Geographic Region
- Exhibit 80: Stem Cells (2005-2012) - European Market Analysis
(Current & Future) by Geographic Region for United Kingdom, Germany,
France, Spain, Denmark and Rest of Europe in US$ Million (Graphical
Representation included)
- Exhibit 81: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown
of European Market Value by Geographic Region for United Kingdom,
Germany, France, Spain, Denmark and Rest of Europe (Graphical
Representation included)
- Market Analysis for Select Rest of Europe Countries
- Exhibit 82: Stem Cells (2005-2012) - Rest of Europe Market
Analysis (Current & Future) by Country for Russia, Sweden,
Switzerland, Poland, Austria and Greece in US$ Million (Graphical
Representation included)
- Exhibit 83: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Rest of Europe Market Value by Geographic Region for
Russia, Sweden, Switzerland, Poland, Austria and Greece
- Analysis by Stem Cell Type
- Exhibit 84: Stem Cells (2005-2012) - European Market Analysis
(Current & Future) by Category for Adult Stem Cells, Cord Blood Stem
Cells and Embryonic Stem Cells in US$ Million (Graphical Representation
included)
- Exhibit 85: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown
of European Market Value by Category for Adult Stem Cells, Cord Blood
Stem Cells and Embryonic Stem Cells
- Analysis by Technology
- Exhibit 86: Stem Cells (2005-2012) - European Market Analysis
(Current & Future) by Stem Cell Technology for Stem Cell (SC)
Transplantation, Cell Based (CB) Genomics, Xenotransplantation, Cord
Blood Banking and Other in US$ Million (Graphical Representation
included)
- Exhibit 87: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown
of European Market Value by Stem Cell Technology for Stem Cell (SC)
Transplantation, Cell Based (CB) Genomics, Xenotransplantation, Cord
Blood Banking and Other
- Analysis by Therapeutic Area
- Exhibit 88: Stem Cells (2005-2012) - European Market Analysis
(Current & Future) by Therapeutic Area for Neurology, Bone and
Cartilage, Cancer, Hematology, Cardiology, Dermatology, Diabetes and
Other in US$ Million (Graphical Representation included)
- Exhibit 89: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown
of European Market Value by Therapeutic Area for Neurology, Bone and
Cartilage, Cancer, Hematology, Cardiology, Dermatology, Diabetes and
Other
- European Stem Cell Market By Country
- B1. The United Kingdom
- The UK Market Scenario
- The UK Cord Blood Banking Sector
- The UK Market Analysis
- Exhibit 90: Stem Cells (2005-2012) - United Kingdom Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 91: List of Cord Blood/Stem Cell Banks in the United Kingdom
- B2. Germany
- German Market Scenario
- German Market Analysis
- Exhibit 92: Stem Cells (2005-2012) - German Market Analysis (Current
& Future) in US$ Million (Graphical Representation included)
- Exhibit 93: List of Cord Blood / Stem Cell Banks in Germany
- B3. France
- French Market Scenario
- Cord Blood Banking in France
- French Market Analysis
- Exhibit 94: Stem Cells (2005-2012) - French Market Analysis (Current
& Future) in US$ Million (Graphical Representation included)
- Exhibit 95: List of Cord Blood /Stem Cell Banks in France
- B4. Spain
- Spanish Market Scenario
- Spanish Market Analysis
- Exhibit 96: Stem Cells (2005-2012) - Spanish Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 97: List of Cord Blood / Stem Cell Banks in Spain
- B5. Denmark
- Danish Market Scenario
- Danish Market Analysis
- Exhibit 98: Stem Cells (2005-2012) - Danish Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 99: List of Major Cord Blood/Stem Cell Banks in Denmark
- B6. Russia
- Russian Market Analysis
- Exhibit 100: Stem Cells (2005-2012) - Russian Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 101: List of Cord Blood /Stem Cell Banks in Russia
- B7. Sweden
- Swedish Market Scenario
- Swedish Market Analysis
- Exhibit 102: Stem Cells (2005-2012) - Swedish Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 103: Cord Blood /Stem Cell Bank in Sweden
- B8. Switzerland
- Swiss Market Scenario
- Swiss Market Analysis
- Exhibit 104: Stem Cells (2005-2012) - Swiss Market Analysis (Current
& Future) in US$ Million (Graphical Representation included)
- Exhibit 105: List of Cord Blood / Stem Cell Banks in Switzerland
- B9. Poland
- Polish Market Scenario
- Polish Market Analysis
- Exhibit 106: Stem Cells (2005-2012) - Polish Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 107: List of Cord Blood/Stem Cell Banks in Poland
- B10. Austria
- Austrian Market Scenario
- Austrian Market Analysis
- Exhibit 108: Stem Cells (2005-2012) - Austrian Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 109: List of Cord Blood/Stem Cell Banks in Austria
- B11. Greece
- Greek Market Scenario
- Greek Market Analysis
- Exhibit 110: Stem Cells (2005-2012) - Greek Market Analysis (Current
& Future) in US$ Million (Graphical Representation included)
- Exhibit 111: List of Cord Blood /Stem Cell Banks in Greece
- Exhibit 112: List of Cord Blood /Stem Cell Banks in Rest of Europe
- C. Asia-Pacific
- Market Analysis
- Exhibit 113: Stem Cells (2005-2012) - Asia-Pacific Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Analysis by Geographic Region
- Exhibit 114: Stem Cells (2005-2012) - Asia-Pacific Market Analysis
(Current & Future) by Geographic Region for India, China, Japan,
Australia and Rest of Asia-Pacific in US$ Million (Graphical
Representation included)
- Exhibit 115: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Asia-Pacific Market Value by Geographic Region for India,
China, Japan, Australia and Rest of Asia-Pacific
- Exhibit 116: List of Major Companies in Asia-Pacific
- Market Analysis for Select Rest of Asia-Pacific Countries
- Exhibit 117: Stem Cells (2005-2012) - Rest of Asia-Pacific
Market Analysis (Current & Future) by Country for South Korea, Hong
Kong, Singapore, New Zealand and Taiwan in US$ Million (Graphical
Representation included)
- Exhibit 118: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Rest of Asia-Pacific Market Value by Geographic Region
for South Korea, Hong Kong, Singapore, New Zealand and Taiwan
- Analysis by Stem Cell Type
- Exhibit 119: Stem Cells (2005-2012) - Asia-Pacific Market Analysis
(Current & Future) by Category for Adult Stem Cells, Cord Blood Stem
Cells and Embryonic Stem Cells in US$ Million (Graphical
Representation included)
- Exhibit 120: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Asia-Pacific Market Value by Category for Adult Stem
Cells, Cord Blood Stem Cells and Embryonic Stem Cells
- Analysis by Technology
- Exhibit 121: Stem Cells (2005-2012) - Asia-Pacific Market Analysis
(Current & Future) by Stem Cell Technology for Stem Cell (SC)
Transplantation, Cell Based (CB) Genomics, Xenotransplantation, Cord
Blood Banking and Other in US$ Million (Graphical Representation
included)
- Exhibit 122: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Asia-Pacific Market Value by Stem Cell Technology for
Stem Cell (SC) Transplantation, Cell Based (CB) Genomics,
Xenotransplantation, Cord Blood Banking and Other
- Analysis by Therapeutic Area
- Exhibit 123: Stem Cells (2005-2012) - Asia-Pacific Market Analysis
(Current & Future) by Therapeutic Area for Neurology, Bone and
Cartilage, Cancer, Hematology, Cardiology, Dermatology, Diabetes and
*Other in US$ Million (Graphical Representation included)
- Exhibit 124: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Asia-Pacific Market Value by Therapeutic Area for
Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology,
Dermatology, Diabetes and Other
- Asia-Pacific Stem Cell Market by Country
- C1. India
- Indian Market Scenario
- The Indian Cord Blood Banking Sector
- Indian Market Analysis
- Exhibit 125: Stem Cells (2005-2012) - Indian Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 126: List of Cord Blood/ Stem Cell Banks in India
- C2. China
- Chinese Market Scenario
- Chinese Market Analysis
- Exhibit 127: Stem Cells (2005-2012) - Chinese Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 128: List of Cord Blood/Stem Cell Banks in China
- C3. Japan
- Japanese Market Scenario
- Japanese Market Analysis
- Exhibit 129: Stem Cells (2005-2012) - Japanese Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 130: List of Cord Blood/Stem Cell Banks in Japan
- C4. Australia
- Australian Market Scenario
- Australian Market Analysis
- Exhibit 131: Stem Cells (2005-2012) - Australian Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 132: List of Cord Blood/Stem Cell Banks in Australia
- C5. South Korea
- South Korean Market Scenario
- The South Korean Cord Blood Banking Sector
- South Korean Market Analysis
- Exhibit 133: Stem Cells (2005-2012) - South Korean Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 134: List of Cord Blood/Stem Cell Banks in South Korea
- C6. Hong Kong
- Hong Kong Market Analysis
- Exhibit 135: Stem Cells (2005-2012) - Hong Kong Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 136: List of Cord Blood/Stem Cell Banks in Hong Kong
- C7. Singapore
- Singaporean Market Scenario
- Singaporean Market Analysis
- Exhibit 137: Stem Cells (2005-2012) - Singaporean Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 138: List of Cord Blood/Stem Cell Banks in Singapore
- C8. New Zealand
- New Zealand Market Scenario
- New Zealand Market Analysis
- Exhibit 139: Stem Cells (2005-2012) - New Zealand Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 140: Cord Blood /Stem Cell Bank in New Zealand
- C9. Taiwan
- Taiwanese Market Scenario
- Taiwanese Market Analysis
- Exhibit 141: Stem Cells (2005-2012) - Taiwanese Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 142: List of Cord Blood/Stem Cell Banks in Taiwan 306
- Exhibit 143: List of Cord Blood/Stem Cell Banks in Rest of
Asia-Pacific
- D. Rest of World
- Market Analysis
- Exhibit 144: Stem Cells (2005-2012) - Rest of World Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Analysis by Geographic Region
- Exhibit 145: Stem Cells (2005-2012) - Rest of World Market
Analysis (Current & Future) by Geographic Region for Latin America,
Middle East and Africa in US$ Million (Graphical Representation
included)
- Exhibit 146: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Rest of World Market Value by Geographic Region for Latin
America, Middle East and Africa
- Exhibit 147: List of Major Companies in Rest of World
- Market Analysis for Select Latin American Countries
- Exhibit 148: Stem Cells (2005-2012) - Latin American Market
Analysis (Current & Future) by Geographic for Brazil, Colombia,
Argentina and Rest of Latin America in US$ Million (Graphical
Representation included)
- Exhibit 149: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Latin American Market Value by Geographic Region for
Brazil, Colombia, Argentina and Rest of Latin America
- Market Analysis for Israel and Rest of Middle East
- Exhibit 150: Stem Cells (2005-2012) - Middle East Market
Analysis (Current & Future) by Geographic Region for Israel and Rest
of Middle East in US$ Million (Graphical Representation included)
- Exhibit 151: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Middle East Market Value by Geographic Region for
Israel and Rest of Middle East
- Analysis by Stem Cell Type
- Exhibit 152: Stem Cells (2005-2012) - Rest of World Market
Analysis (Current & Future) by Category for Adult Stem Cells, Cord
Blood Stem Cells and Embryonic Stem Cells in US$ Million (Graphical
Representation included)
- Exhibit 153: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Rest of World Market Value by Category for Adult Stem
Cells, Cord Blood Stem Cells and Embryonic Stem Cells
- Analysis by Technology
- Exhibit 154: Stem Cells (2005-2012) - Rest of World Market
Analysis (Current & Future) by Stem Cell Technology for Stem Cell (SC)
Transplantation, Cell Based (CB) Genomics, Xenotransplantation, Cord
Blood Banking and Other in US$ Million (Graphical Representation
included)
- Exhibit 155: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Rest of World Market Value by Stem Cell Technology for
Stem Cell (SC) Transplantation, Cell Based (CB) Genomics,
Xenotransplantation, Cord Blood Banking and Other
- Analysis by Therapeutic Area
- Exhibit 156: Stem Cells (2005-2012) - Rest of World Market
Analysis (Current & Future) by Therapeutic Area for Neurology, Bone
and Cartilage, Cancer, Hematology, Cardiology, Dermatology, Diabetes
and *Other in US$ Million (Graphical Representation included)
- Exhibit 157: Stem Cells (2006, 2009 and 2012) - Percentage
Breakdown of Rest of World Market Value by Therapeutic Area for
Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology,
Dermatology, Diabetes and Other
- Rest of World Stem Cell Market by Country
- D1. Brazil
- Brazilian Market Scenario
- Brazilian Market Analysis
- Exhibit 158: Stem Cells (2005-2012) - Brazilian Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 159: List of Cord Blood/ Stem Cell Banks in Brazil
- D2. Colombia
- Colombian Market Scenario
- Colombian Market Analysis
- Exhibit 160: Stem Cells (2005-2012) - Colombian Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 161: List of Cord Blood/Stem Cell Bank in Colombia
- D3. Argentina
- Argentinean Market Scenario
- Argentinean Market Analysis
- Exhibit 162: Stem Cells (2005-2012) - Argentinean Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 163: List of Cord Blood/Stem Cell Banks in Argentina
- D4. Rest of Latin America
- Rest of Latin America Market Analysis
- Exhibit 164: Stem Cells (2005-2012) - Rest of Latin America Market
Analysis (Current & Future) in US$ Million (Graphical Representation
included)
- Exhibit 165: List of Cord Blood/Stem Cell Banks in Rest of Latin
America
- D5. Israel
- Israeli Market Scenario
- Israeli Market Analysis
- Exhibit 166: Stem Cells (2005-2012) - Israeli Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 167: List of Cord Blood/Stem Cell Banks in Israel
- D6. Rest of Middle East
- Rest of Middle East Market Analysis
- Exhibit 168: Stem Cells (2005-2012) - Rest of Middle East Market
Analysis (Current & Future) in US$ Million (Graphical Representation
included)
- D7. South Africa
- South African East Market Scenario
- South African East Market Analysis
- Exhibit 169: Stem Cells (2005-2012) - South African Market Analysis
(Current & Future) in US$ Million (Graphical Representation included)
- Exhibit 170: List of Cord Blood/Stem Cell Banks in South Africa
- 7. Stem Cell Research - The Industry Outlook
V. CORPORATE DIRECTORY
|
